Pearson J. Michael 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Oct 26, 2012
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock, no par value
2012-10-24−25,787→ 6,462,643 total
Footnotes (2)
- [F1]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Matching Restricted Share Units.
- [F2]This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.